Long-term outcome of percutaneous ethanol injection therapy for minimum-sized hepatocellular carcinoma

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 13

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

280

HTML

2045

Figures (1-3)

224

Tables (1-6)

201

Sum=2750

Apr 7, 2008 (publication date) through Nov 3, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Liver Cancer

World J Gastroenterol. Apr 7, 2008; 14(13): 1997-2002
Published online Apr 7, 2008. doi: 10.3748/wjg.14.1997

Table 6 Recurrence of HCC initially treated by PEI (n = 25)

Location of recurrence
Same segment	8 (32.0%)
Same and other segments	7 (28.0%)
Other segments	8 (32.0%)
Others¹	2 (8.0%)
Tumor diameter at detection (mm)
≤ 10	8 (32.0%)
11-15	9 (36.0%)
16-20	4 (16.0%)
21-30	2 (8.0%)
≥ 31	0
Others	2 (8.0%)

¹In two cases, tumor thrombus was seen in portal vein and HCC metastasizing to distant site (sacrum and lumbar vertebra), respectively.

Citation: Taniguchi M, Kim SR, Imoto S, Ikawa H, Ando K, Mita K, Fuki S, Sasase N, Matsuoka T, Kudo M, Hayashi Y. Long-term outcome of percutaneous ethanol injection therapy for minimum-sized hepatocellular carcinoma. World J Gastroenterol 2008; 14(13): 1997-2002
URL: https://www.wjgnet.com/1007-9327/full/v14/i13/1997.htm
DOI: https://dx.doi.org/10.3748/wjg.14.1997